- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Lowering of C-Reactive Protein
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-29
DOI
10.3389/fimmu.2020.619564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules
- (2020) Beatriz G. de la Torre et al. MOLECULES
- Prognostic value of C-reactive protein in patients with COVID-19
- (2020) Xiaomin Luo et al. CLINICAL INFECTIOUS DISEASES
- Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
- (2020) Karishma Dhuri et al. Journal of Clinical Medicine
- Selective C‐reactive protein‐apheresis in patients
- (2019) Wolfgang Ries et al. THERAPEUTIC APHERESIS AND DIALYSIS
- PentraSorb C‐Reactive Protein: Characterization of the Selective C‐Reactive Protein Adsorber Resin
- (2019) Stephan Mattecka et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Evolution of C-Reactive Protein
- (2019) Asmita Pathak et al. Frontiers in Immunology
- Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis
- (2019) Wei Huang et al. Journal of Cardiothoracic Surgery
- C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions
- (2019) Rachel V. Jimenez et al. Frontiers in Immunology
- Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017–2019
- (2019) Jacqueline Rüger et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- NGL viewer: web-based molecular graphics for large complexes
- (2018) Alexander S Rose et al. BIOINFORMATICS
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance
- (2018) Rachel V. Jimenez et al. Frontiers in Immunology
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy
- (2018) Stephen K Burley et al. NUCLEIC ACIDS RESEARCH
- The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs
- (2018) Mark. B. Pepys Frontiers in Immunology
- Pentraxins and Fc Receptor-Mediated Immune Responses
- (2018) Jinghua Lu et al. Frontiers in Immunology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker
- (2016) Anne Helene Køstner et al. JOURNAL OF SURGICAL ONCOLOGY
- Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
- (2016) Maria Thomsen et al. Oncotarget
- C-reactive protein and inflammation: conformational changes affect function
- (2015) Yi Wu et al. BIOLOGICAL CHEMISTRY
- Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in patients with penile squamous cell carcinoma
- (2015) Zai-Shang Li et al. BJU INTERNATIONAL
- Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637
- (2015) Yoonseo Kim et al. MOLECULAR AND CELLULAR BIOLOGY
- Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis
- (2015) Marshelle S Warren et al. ARTHRITIS RESEARCH & THERAPY
- Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1 Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression
- (2014) T. Nishikawa et al. JOURNAL OF IMMUNOLOGY
- Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models
- (2014) Alexander J. Szalai et al. MEDIATORS OF INFLAMMATION
- Recognition Functions of Pentameric C-Reactive Protein in Cardiovascular Disease
- (2014) Alok Agrawal et al. MEDIATORS OF INFLAMMATION
- Effects of an Antisense Oligonucleotide Inhibitor of C‐Reactive Protein Synthesis on the Endotoxin Challenge Response in Healthy Human Male Volunteers
- (2014) Robert Noveck et al. Journal of the American Heart Association
- C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy
- (2013) Rishi Puri et al. CIRCULATION
- High-Sensitivity C-Reactive Protein Levels and Cancer Mortality
- (2012) Y.-J. Ko et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans
- (2012) Ayo P. Doumatey et al. HUMAN MOLECULAR GENETICS
- A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans
- (2012) Nicholas R Jones et al. Molecular Therapy-Nucleic Acids
- Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice
- (2011) Nicholas R. Jones et al. ARTHRITIS AND RHEUMATISM
- Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
- (2011) Kristine H. Allin et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The Appearance of Acute Phase Protein After Induced Fever in Man
- (2010) PER HEDLUND et al. ACTA MEDICA SCANDINAVICA
- Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli
- (2010) M. B. PEPYS et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CRP is a novel ligand for the oxidized LDL receptor LOX-1
- (2009) Heather H. Shih et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
- (2009) Kristine H. Allin et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of Signal Transducer and Activator of Transcription 3 Enhanceosome Formation by Apurinic/Apyrimidinic Endonuclease 1 in Hepatic Acute Phase Response
- (2009) Sutapa Ray et al. MOLECULAR ENDOCRINOLOGY
- Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects
- (2008) Y. Fujita et al. CLINICAL CHEMISTRY
- C-reactive protein and coronary heart disease: a critical review
- (2008) J. P. Casas et al. JOURNAL OF INTERNAL MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exaggerated Neointima Formation in Human C-Reactive Protein Transgenic Mice Is IgG Fc Receptor Type I (FcγRI)-Dependent
- (2007) Dongqi Xing et al. AMERICAN JOURNAL OF PATHOLOGY
- Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice
- (2007) Glenys A. Tennent et al. ATHEROSCLEROSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started